Neocarzilin Inhibits Cancer Cell Proliferation via BST‑2 Degradation, Resulting in Lipid Raft-Trapped EGFR
Josef Braun,
Yudong Hu,
Adrian T. Jauch,
Thomas F. Gronauer,
Julia Mergner,
Nina C. Bach,
Franziska R. Traube,
Stefan Zahler,
Stephan A. Sieber
Affiliations
Josef Braun
TUM School of Natural Sciences, Department of Bioscience, Chair of Organic Chemistry II, Center for Functional Protein Assemblies (CPA), Technical University of Munich (TUM), Garching near Munich, Germany
Yudong Hu
Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University in Munich (LMU), Munich, Germany
Adrian T. Jauch
Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University in Munich (LMU), Munich, Germany
Thomas F. Gronauer
TUM School of Natural Sciences, Department of Bioscience, Chair of Organic Chemistry II, Center for Functional Protein Assemblies (CPA), Technical University of Munich (TUM), Garching near Munich, Germany
Julia Mergner
Bavarian Center for Biomolecular Mass Spectrometry at Klinikum rechts der Isar (BayBioMS@MRI), Technical University of Munich (TUM), Munich, Germany
Nina C. Bach
TUM School of Natural Sciences, Department of Bioscience, Chair of Organic Chemistry II, Center for Functional Protein Assemblies (CPA), Technical University of Munich (TUM), Garching near Munich, Germany
Franziska R. Traube
Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Stuttgart, Germany
Stefan Zahler
Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University in Munich (LMU), Munich, Germany
Stephan A. Sieber
TUM School of Natural Sciences, Department of Bioscience, Chair of Organic Chemistry II, Center for Functional Protein Assemblies (CPA), Technical University of Munich (TUM), Garching near Munich, Germany
